| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 857 | 8.002 | 0 | 1.977 | 10.868 | 18.583 | 49.630 | 56.627 |
| Total Income - EUR | - | - | 857 | 8.002 | 0 | 1.977 | 10.868 | 18.585 | 49.650 | 56.840 |
| Total Expenses - EUR | - | - | 426 | 7.709 | 1.938 | 3.073 | 4.899 | 9.999 | 22.601 | 31.733 |
| Gross Profit/Loss - EUR | - | - | 430 | 292 | -1.938 | -1.096 | 5.969 | 8.586 | 27.049 | 25.107 |
| Net Profit/Loss - EUR | - | - | 405 | 52 | -1.938 | -1.154 | 5.643 | 8.169 | 26.563 | 23.436 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Priemed Mnp S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 981 | 602 | 1.643 | 1.525 | 815 | 1.485 | 1.292 |
| Current Assets | - | - | 912 | 2.728 | 1.099 | 1.814 | 7.753 | 10.402 | 27.751 | 24.201 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 46 | 6.750 | 17.982 | 14.329 |
| Cash | - | - | 912 | 2.728 | 1.099 | 1.814 | 7.707 | 3.651 | 9.769 | 9.872 |
| Shareholders Funds | - | - | 448 | 492 | -1.455 | -2.582 | 3.119 | 11.297 | 26.611 | 23.484 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 463 | 3.218 | 3.156 | 6.039 | 6.159 | 0 | 2.685 | 2.052 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Priemed Mnp S.r.l.